Related Experiment Videos
[Survival after gastrectomy for cancer. 209 cases]
Y P Le Treut1, C Capobianco, G Botti
1Service de Chirurgie digestive, Hôpital de La Conception, Marseille.
Presse Medicale (Paris, France : 1983)
|September 26, 1992
Summary
This study on gastric adenocarcinoma resections found curative rates of 73.6% and a 5-year survival of 38%. Proximal lymph node involvement (N1) did not significantly impact prognosis, while pedicular (N2) involvement allowed for prolonged survival.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Oncology
Context:
- Gastric adenocarcinoma presents a significant global health challenge.
- Surgical resection remains a primary treatment modality.
- Long-term outcomes following gastrectomy require continuous evaluation.
Purpose:
- To present long-term results of 209 gastrectomies for gastric adenocarcinoma.
- To analyze survival rates based on tumor stage and lymph node involvement.
- To assess the prognostic significance of lymph node status in gastric cancer.
Summary:
- A total of 209 gastrectomies were analyzed, with 154 (73.6%) achieving curative resection.
- Five-year actuarial survival was 38% overall, 52% for curative resections, and 2% for palliative resections.
- Tumor stage and lymph node involvement (N1, N2) were evaluated for their impact on survival post-curative resection.
Impact:
- Findings suggest that proximal (N1) lymph node involvement has minimal prognostic significance.
- Pedicular (N2) lymph node involvement is not incompatible with prolonged survival after curative gastrectomy.
- This research contributes to understanding prognostic factors in gastric cancer surgery.